反応式
CC(C)=C[CH2:4][CH2:5]/[C:6](/[CH3:27])=[CH:7]/[CH2:8]C/C(/C)=C/CCC1(C)OC2C=CC(O)=CC=2CC1.[CH3:29][C:30]1[CH:36]=[C:35]([OH:37])[C:34]([CH3:38])=[CH:33][C:31]=1[OH:32].OC(C)(C=C)C=C>>[CH:5]([C:6]1([CH3:27])[CH2:7][CH2:8][C:33]2[C:31](=[C:30]([CH3:29])[CH:36]=[C:35]([OH:37])[C:34]=2[CH3:38])[O:32]1)=[CH2:4]参加物
4
実験手順
In the second method for forming the single enantiomer chroman diol, (2S) 2-hydroxymethyl-6-hydroxy-2,5,8-trimethylchroman for use as starting material in the present tocotrienol syntheses, a suitably monoprotected 2,5-dimethylhydroquinone is reacted with the compound 3-hydroxy-3-methyl-1,4-pentadiene to produce 2-vinyl-2,5,8-trimethylchroman-6-ol:
出典と根拠
- ORDレコード
- ord-d298fe6527dc4be8bf41eb03535ea447
- 出典データセット
- uspto-grants-2006_05
- 特許番号
- US07038067B2
関連ノート
読み込み中…